Wayland Group Announces Appointment of General Counsel
TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce the appointment of Matthew McLeod who will assume the role of General Counsel.
The Company is pleased to welcome Matthew to the newly created role. Mr. McLeod was called to the Ontario bar in 2013 and the New York bar in 2014, holds a BEng and an MBA from the Royal Military College of Canada as well as a JD from Western University. He was previously a corporate lawyer with Osler, Hoskin & Harcourt LLP in New York City and most recently worked with Sigma Systems based in Toronto, Ontario where he held the role of Head of Legal and Compliance. Mr. McLeod’s merger and acquisition experience will be invaluable to the Company and this latest appointment further strengthens the Company’s corporate expertise and will allow Wayland Group to continue its global expansion.
“I am thrilled to be joining Wayland at a very exciting time for the company and the cannabis industry. The management team, and the board of directors are an impressive combination of industry leading talent and ambition, and I look forward to helping Wayland continue its expansion and growth” stated Matthew McLeod.
Ben Ward, CEO of Wayland Group stated, “We are very excited about Matt joining our growing team. Our transaction execution and compliance capabilities are immediately strengthened with his addition.”
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
About Wayland Group
Wayland is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.
Forward Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed acquisition and the plans for the assets of the entities being acquired, its plan to achieve EU-GMP production standards in its German operations and GACP standards in all international cultivation operations and the plan to create a reliable and consistent mass supply of cannabinoid isolates for the global market. As noted above completion of the transactions are subject to a number of conditions and there is no certainty that either transaction will be completed on the terms set forth in this press release or at all. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.